Kristina Burow is a biotech VC leader at ARCH Venture Partners who specializes in building new companies from scratch around emerging biology, particularly in transformative neuropsychiatry and neuroscience areas like first-in-class drugs for schizophrenia that target biologically defined patient subgroups rather than broad diagnoses. She has been closely involved in creating or early shaping of companies like Neumora, Orbital Therapeutics, and Boundless Bio, and her early career included helping found Sapphire Energy, an algae-based renewable energy startup that showcases her appetite for deep-tech, high-science platforms at the edge of what's commercially proven. Kristina Burow is a biotech VC leader at ARCH Venture Partners who specializes in building new companies from scratch around emerging biology, particularly in transformative neuropsychiatry and neuroscience areas like first-in-class drugs for schizophrenia that target biologically defined patient subgroups rather than broad diagnoses. She has been closely involved in creating or early shaping of companies like Neumora, Orbital Therapeutics, and Boundless Bio, and her early career included helping found Sapphire Energy, an algae-based renewable energy startup that showcases her appetite for deep-tech, high-science platforms at the edge of what's commercially proven.